labetalol has been researched along with prazosin in 79 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 46 (58.23) | 18.7374 |
1990's | 14 (17.72) | 18.2507 |
2000's | 7 (8.86) | 29.6817 |
2010's | 10 (12.66) | 24.3611 |
2020's | 2 (2.53) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chen, X; Lin, X; Skolnik, S; Wang, J | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Gunaydin, H; Sun, Y; Weiss, MM | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
Gifford, RW; Tarazi, RC; Wollam, GL | 1 |
Hayduk, K | 1 |
Kaplan, NM; Ram, CV | 1 |
Andréjak, M; Bataille, P; Fournier, A; Gheerbrant, JD; Hardin, JM; Makdassi, R | 1 |
Lund-Johansen, P | 1 |
Goldberg, SR; Schindler, CW; Tella, SR | 1 |
Ishizaki, A; Kim, S; Matsukawa, M; Shiratsuchi, T; Uchiyama, M; Yamamoto, T | 1 |
Latini, R; Mennini, T; Riva, E | 1 |
Lund-Johansen, P; Omvik, P | 1 |
Nakajima, M; Ueda, M | 1 |
Allen, J; Forman, A; Maigaard, S; Skajaa, K | 1 |
Cohen, M; Dimino, L; el-Sherif, N; Feit, A; Gaffeny, D; Heller, J; Holtzman, R; Kaplan, N; Ram, S; Venkata, C | 1 |
Chin, WP; Imai, S; Nakagawa, Y; Nakahara, H | 1 |
Imai, S; Nakahara, H; Nakazawa, M; Takeda, K | 1 |
Louis, WJ; Rand, MJ; Story, DF; Tung, LH | 1 |
Bartsch, W; Böhm, E; Hooper, RG; Sponer, G; Strein, K | 1 |
Mikami, H; Ogihara, T | 1 |
Farry, JP; Fischl, SJ; Krell, MJ; Tighe, MJ | 1 |
Rietbrock, N; Woodcock, BG | 1 |
Honda, K; Miyata-Osawa, A; Nakagawa, C; Shiono, K; Takenaka, T | 1 |
Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M | 1 |
Calder, AA; Forbes, CD; Greer, IA; McLaren, M; Walker, JJ | 1 |
Anderson, RJ; Reed, WG | 1 |
Materson, BJ | 1 |
Cook, CA; Modrak, JB; Sirgo, MA | 1 |
Kanno, M; Nakaya, H; Tohse, N | 1 |
Clerici, C; Harf, A; Macquin-Mavier, I | 1 |
Pandhi, P; Sharma, PL | 1 |
Dollery, CT; Warren, JB | 1 |
Akashi, A; Hashimoto, H; Kanda, A; Tanaka, M | 1 |
Gorwit, JI; Gray, JM; Silberman, HM | 1 |
Catapano, MS; Marx, JA | 1 |
Matsumura, Y; Morimoto, S | 1 |
Bacher, S; Beck, A; Kraupp, O; Raberger, G; Skoda, H | 1 |
Donker, AJ; May, JF; Schuurman, FH; ten Berge, BS; van der Veur, E; Wesseling, H | 1 |
Bouffioux, CR; Penders, L | 1 |
Reid, JL; Rubin, PC | 1 |
Anand, MP | 1 |
Wallin, JD | 1 |
Birkenhäger, WH; De Leeuw, PW | 1 |
Graham, RM | 1 |
Bengtsson, C | 1 |
Drayer, JI; Weber, MA | 1 |
Dukes, ID; Vaughan Williams, EM | 1 |
Elliott, HL; Reid, JL; Sumner, DJ | 1 |
Andrén, L; Eggertsen, R; Hansson, L; Hedner, T; Karlberg, BE | 1 |
Ram, CV | 1 |
Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ | 1 |
Song, YC | 1 |
Gellatly, R; Hill, A; Mennie, BA; Stokes, GS | 1 |
Buch, J; Rasmussen, S | 1 |
Rahn, KH | 1 |
Hua, AS; Kincaid-Smith, P; Macdonald, I; Thomas, GW; Whitworth, JA; Woo, KT | 1 |
Kinami, J; Maruyama, K; Nagatomo, T; Sasaki, K; Tsuchihashi, H | 1 |
Bilello, K; Cole, F; Jaffin, J; Malcolm, D; Powell, C; Schultz, S | 1 |
Appalsamy, M; Mosqueda-Garcia, R; Robertson, D; Tseng, CJ | 1 |
Janssen, BJ; Oosting, J; Struyker-Boudier, HA; Tyssen, CM | 1 |
Gould, SJ; Houlston, RS; Hurst, JA; Roberts, A; Tingey, WG | 1 |
Frewin, DB; Metcalfe, IR; Russell, WJ; Tonkin, AL | 1 |
Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
Campisi, J; Fleshner, M; Greenwood, BN; Johnson, JD; Kennedy, SL; Nickerson, M; Sharkey, CM | 1 |
Armstrong, SP; Ayoub, MA; Mustafa, S; Pfleger, KD; See, HB; Seeber, RM; Ventura, S; White, CW | 1 |
Ong, CT; Sung, SF; Tong, SH; Wu, CS | 1 |
Alawi, KM; Aubdool, AA; Brain, SD; Keeble, JE; Liang, L; Psefteli, MP; Vepa, A; Wilde, E | 1 |
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM | 1 |
12 review(s) available for labetalol and prazosin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Antihypertensive drugs: clinical pharmacology and therapeutic use.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics | 1977 |
[New antihypertensive agents].
Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chemical Phenomena; Chemistry; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Labetalol; Minoxidil; Prazosin | 1979 |
Adverse effects of antihypertensive treatment.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Enzyme Inhibitors; Humans; Hypertension; Labetalol; Methyldopa; Prazosin; Quality of Life; Sympatholytics; Vasodilator Agents | 1986 |
The usefulness of alpha-adrenoceptor blockade in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Antihypertensive Agents; Humans; Hypertension; Indoramin; Labetalol; Piperazines; Prazosin | 1988 |
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male; Phenoxybenzamine; Phentolamine; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha | 1984 |
Hypertension--drug management.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Calcium Channel Blockers; Captopril; Diazoxide; Humans; Hypertension; Indoramin; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin; Sympatholytics; Vasodilator Agents; Verapamil | 1982 |
Alpha-adrenergic blockade in the treatment of essential hypertension.
Topics: Adrenergic alpha-Antagonists; Biomechanical Phenomena; Hemodynamics; Humans; Hypertension; Indoramin; Labetalol; Phenoxybenzamine; Prazosin; Receptors, Adrenergic, alpha | 1983 |
Selective alpha 1-adrenergic antagonists: therapeutically relevant antihypertensive agents.
Topics: Adrenergic alpha-Antagonists; Ethanolamines; Humans; Hypertension; Indoramin; Labetalol; Prazosin; Receptors, Adrenergic, alpha; Vascular Resistance | 1984 |
Central and peripheral blockade of the sympathetic nervous system.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics | 1984 |
Hypertensive crisis.
Topics: Antihypertensive Agents; Brain Diseases; Cerebrovascular Disorders; Clonidine; Coronary Disease; Diazoxide; Eclampsia; Emergencies; Female; Humans; Hydralazine; Hypertension; Hypertension, Malignant; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Phentolamine; Prazosin; Pregnancy; Pulmonary Edema; Trimethaphan | 1984 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
9 trial(s) available for labetalol and prazosin
Article | Year |
---|---|
The effects of labetalol and prazosin on exercise haemodynamics in hypertensive patients.
Topics: Adult; Aged; Female; Headache; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Physical Exertion; Prazosin | 1991 |
Effects of prazosin and labetalol on blood pressure control and blood lipid levels in patients with mild-to-moderate essential hypertension.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Lipids; Male; Middle Aged; Prazosin | 1989 |
Comparative effects of beta-, alpha- and combined beta- plus alpha-adrenoceptor blocking agents in stress-induced increase in arterial blood pressure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Atenolol; Blood Pressure; Cold Temperature; Double-Blind Method; Heart Rate; Humans; Isometric Contraction; Labetalol; Male; Prazosin; Propranolol; Random Allocation; Stress, Physiological | 1987 |
Comparison of labetalol and prazosin in hypertensive patients using automated ambulatory monitoring.
Topics: Activities of Daily Living; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Middle Aged; Monitoring, Physiologic; Prazosin; Random Allocation | 1988 |
A comparison of labetalol and prazosin combined with atenolol in non-responders to atenolol plus hydrochlorothiazide in uncomplicated hypertension.
Topics: Adult; Atenolol; Chlorothiazide; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Prazosin; Random Allocation; Time Factors | 1985 |
Alpha-blockers in the treatment of benign prostatic hypertrophy: physiological basis and review of the problem.
Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Double-Blind Method; Humans; Labetalol; Male; Phenoxybenzamine; Phentolamine; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha | 1984 |
Circulatory effects of noise.
Topics: Adult; Catecholamines; Female; Hemodynamics; Humans; Hypertension; Labetalol; Male; Middle Aged; Noise; Prazosin; Renin | 1983 |
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin | 1984 |
On the combination of alpha- and beta-adrenoceptor blockade in hypertension.
Topics: Adult; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Prazosin; Quinazolines; Random Allocation | 1983 |
59 other study(ies) available for labetalol and prazosin
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model.
Topics: Adenosine; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Sub-Family B Member 4; ATP-Binding Cassette Transporters; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Dibenzocycloheptenes; Diketopiperazines; Drug Discovery; Heterocyclic Compounds, 4 or More Rings; Humans; Intestinal Absorption; Mass Spectrometry; Models, Biological; Neoplasm Proteins; Pharmaceutical Preparations; Predictive Value of Tests; Propionates; Quinolines; Substrate Specificity | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
De novo prediction of p-glycoprotein-mediated efflux liability for druglike compounds.
Topics: | 2013 |
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Alpha- and beta-receptor blocking drugs in the treatment of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Humans; Hypertension; Labetalol; Prazosin; Receptors, Adrenergic; Sympathetic Nervous System | 1979 |
[Clinical pharacology of the new antihypertensive drugs: renin-angiotensin system antagonists, recent vasodilators and dopaminergic agonists].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dopamine Antagonists; Humans; Labetalol; Minoxidil; Nifedipine; Prazosin; Renin; Saralasin; Tetrahydronaphthalenes; Vasodilator Agents | 1979 |
Comparative haemodynamic effects of labetalol, timolol, prazosin and the combination of tolamolol and prazosin.
Topics: Adult; Blood Pressure; Drug Combinations; Ethanolamines; Hemodynamics; Humans; Labetalol; Male; Middle Aged; Physical Exertion; Prazosin; Propanolamines; Quinazolines; Rest; Timolol | 1979 |
Adrenoceptor mechanisms in the cardiovascular effects of cocaine in conscious squirrel monkeys.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Cocaine; Heart Rate; Labetalol; Male; Phentolamine; Prazosin; Propanolamines; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Saimiri; Yohimbine | 1992 |
[Anesthetic management of a patient with Sipple syndrome].
Topics: Administration, Oral; Adult; Anesthesia, Inhalation; Humans; Labetalol; Male; Multiple Endocrine Neoplasia; Prazosin | 1991 |
The alpha- and beta-adrenoceptor blocking activities of labetalol and its RR-SR (50:50) stereoisomers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Cerebral Cortex; Dose-Response Relationship, Drug; Heart; Heart Rate; In Vitro Techniques; Isoproterenol; Labetalol; Male; Myocardium; Phenylephrine; Prazosin; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereoisomerism | 1991 |
The initial hemodynamic response to newer antihypertensive agents at rest and during exercise: review of visacor, doxazosin, nisoldipine, tiapamil, perindoprilat, pinacidil, dilevalol, and carvedilol.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzeneacetamides; Calcium Channel Blockers; Carbazoles; Carvedilol; Doxazosin; Female; Guanidines; Hemodynamics; Humans; Indoles; Labetalol; Male; Middle Aged; Nisoldipine; Pinacidil; Potassium Channels; Prazosin; Propanolamines; Propylamines; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Tiapamil Hydrochloride | 1990 |
Effects of dilevalol on adrenoceptors in isolated cat arteries.
Topics: Animals; Arteries; Cats; Clonidine; Dinoprost; Electric Stimulation; Female; In Vitro Techniques; Labetalol; Male; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Vasoconstriction; Yohimbine | 1990 |
Effects of vasodilators on isolated human uteroplacental arteries.
Topics: Angiotensin II; Arteries; Chorionic Villi; Dinoprost; Female; Humans; Hydralazine; Labetalol; Nitrendipine; Norepinephrine; Potassium; Prazosin; Pregnancy; Uterus; Vasoconstriction; Vasodilator Agents; Vasopressins | 1991 |
Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Decerebrate State; Labetalol; Male; Phenylephrine; Prazosin; Propanolamines; Rats; Rats, Inbred Strains; Vasodilation; Yohimbine | 1985 |
Role of the alpha-adrenergic blocking effect in the acute hypotensive effect of beta-adrenergic blocking drugs with alpha-blocking activities in conscious SHR.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Heart Rate; Hydralazine; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Time Factors | 1985 |
Cardiac alpha-adrenoceptors: postjunctional and prejunctional.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic alpha-Antagonists; Animals; Calcium; Dioxanes; Dose-Response Relationship, Drug; Female; Heart Conduction System; Heart Rate; Idazoxan; In Vitro Techniques; Labetalol; Methoxamine; Myocardial Contraction; Myocardium; Norepinephrine; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Verapamil | 1986 |
Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
Topics: Animals; Blood Pressure; Carbazoles; Carvedilol; Disease Models, Animal; Guanethidine; Hypotension, Orthostatic; Labetalol; Prazosin; Propanolamines; Rabbits; Risk; Vasodilator Agents | 1987 |
[Clinical application of adrenoceptor blockers in the treatment of hypertension].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Humans; Hypertension; Labetalol; Prazosin; Propanolamines; Quinazolines | 1989 |
[Circadian rise of blood pressure and combined alpha-beta adrenoceptor blockade].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Circadian Rhythm; Cold Temperature; Drug Therapy, Combination; Humans; Hypertension; Indoramin; Labetalol; Prazosin; Propranolol | 1985 |
Autonomic and antihypertensive activity of oral amosulalol (YM-09538), a combined alpha- and beta-adrenoceptor blocking agent in conscious rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Ethanolamines; Heart Rate; Isoproterenol; Labetalol; Male; Phenylephrine; Prazosin; Propranolol; Rats; Rats, Inbred SHR; Rats, Inbred Strains | 1985 |
[Hypertension in pregnancy: proposed monitoring and therapy].
Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular | 1985 |
A comparative study of the effects of adrenoceptor antagonists on platelet aggregation and thromboxane generation.
Topics: Adrenergic beta-Antagonists; Dose-Response Relationship, Drug; Humans; In Vitro Techniques; Labetalol; Pindolol; Platelet Aggregation; Prazosin; Propranolol; Thromboxane A2; Thromboxane B2 | 1985 |
Current concepts in treatment of hypertensive urgencies.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Central Nervous System; Clonidine; Diuretics; Ganglia; Guanethidine; Humans; Hypertension; Labetalol; Minoxidil; Patient Compliance; Prazosin; Sympatholytics; Vasodilator Agents | 1986 |
Hypertensive therapy in blacks. Significance of pathophysiologic observations.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Black or African American; Diuretics; Humans; Hypertension; Labetalol; Prazosin | 1986 |
Electrophysiological effects of amosulalol, a new alpha- and beta-adrenoceptor blocker, in isolated rabbit papillary muscles.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Electric Stimulation; Ethanolamines; Female; Heart; In Vitro Techniques; Kinetics; Labetalol; Male; Papillary Muscles; Prazosin; Propranolol; Rabbits; Time Factors | 1986 |
Failure of enhancement by labetalol of bronchopulmonary effects of histamine in guinea-pigs: independence of alpha-adrenoceptor antagonism.
Topics: Adrenergic alpha-Antagonists; Animals; Bronchi; Guinea Pigs; Histamine; Labetalol; Lung; Male; Neural Conduction; Plethysmography; Prazosin; Propranolol; Respiration | 1987 |
Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Decerebrate State; Dose-Response Relationship, Drug; Drug Interactions; Hydralazine; Hypertension; Labetalol; Prazosin; Propanolamines; Rats; Rats, Inbred SHR; Vasodilator Agents | 1988 |
Management of urgent hypertension: a comparison of oral treatment regimens in the emergency department.
Topics: Administration, Oral; Antihypertensive Agents; Captopril; Clonidine; Drug Administration Schedule; Emergency Service, Hospital; Hemodynamics; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Prazosin | 1986 |
Effects of labetalol on renin release from rat kidney cortical slices.
Topics: Animals; In Vitro Techniques; Isoproterenol; Kidney Cortex; Labetalol; Male; Norepinephrine; Prazosin; Propranolol; Rats; Rats, Inbred Strains; Renin | 1986 |
Characterization of vasodilators by comparison of their effects on blood pressure, counterregulation and myocardial oxygen demand in conscious normotensive dogs.
Topics: Animals; Blood Pressure; Dihydralazine; Dogs; Female; Heart Rate; Isosorbide Dinitrate; Labetalol; Male; Molsidomine; Myocardium; Oxygen Consumption; Piperazines; Prazosin; Pyridazines; Renin; Sydnones; Vasodilator Agents | 1985 |
Alpha-blockers and converting enzyme inhibitors.
Topics: Adrenergic alpha-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Heart Failure; Humans; Hypertension; Indoramin; Kinetics; Labetalol; Prazosin | 1983 |
Antihypertensives and their impact on renal function.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Captopril; Central Nervous System; Clonidine; Glomerular Filtration Rate; Humans; Kidney; Labetalol; Methyldopa; Prazosin; Renal Circulation; Vasodilator Agents | 1983 |
Impairment of physical performance after treatment with beta blockers and alpha blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alprenolol; Heart Rate; Humans; Hydrochlorothiazide; Labetalol; Male; Metoprolol; Physical Exertion; Pindolol; Prazosin; Propranolol; Running | 1984 |
Electrophysiological effects of alpha-adrenoceptor antagonists in rabbit sino-atrial node, cardiac Purkinje cells and papillary muscles.
Topics: Action Potentials; Adrenergic alpha-Antagonists; Animals; Ethanolamines; Female; Heart; Heart Rate; In Vitro Techniques; Labetalol; Male; Neuromuscular Depolarizing Agents; Papillary Muscles; Phentolamine; Prazosin; Purkinje Cells; Rabbits; Sinoatrial Node | 1984 |
Analysis of the pressor dose response.
Topics: Blood Pressure; Dose-Response Relationship, Drug; Doxazosin; Drug Interactions; Epinephrine; Ethanolamines; Humans; Labetalol; Mathematics; Models, Biological; Norepinephrine; Prazosin; Pressoreceptors | 1982 |
[Clinical use of new antihypertensives].
Topics: Alkaloids; Antihypertensive Agents; Benzylisoquinolines; Captopril; Diazoxide; Diterpenes; Humans; Hypertension; Labetalol; Minoxidil; Nifedipine; Nitroprusside; Prazosin | 1984 |
The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
Topics: Adult; Aged; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Metoprolol; Middle Aged; Myocardial Contraction; Prazosin; Quinazolines; Systole | 1983 |
[Recent antihypertensive agents].
Topics: Antihypertensive Agents; Guanfacine; Guanidines; Humans; Hypertension; Labetalol; Minoxidil; Phenylacetates; Prazosin | 1982 |
Use of labetalol in moderate to severe hypertension.
Topics: Benzothiadiazines; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Middle Aged; Prazosin; Sodium Chloride Symporter Inhibitors | 1980 |
Nipradilol displays a unique pharmacological profile of affinities for the different alpha 1-adrenoceptor subtypes.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Ethanolamines; Guinea Pigs; In Vitro Techniques; Isomerism; Labetalol; Male; Prazosin; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha | 1993 |
Diaspirin crosslinked hemoglobin (DCLHb): control of pressor effect with anti-hypertensive agents.
Topics: Animals; Antihypertensive Agents; Aspirin; Blood Pressure; Blood Substitutes; Hemoglobins; Hypertension; Labetalol; Nicardipine; Nitroglycerin; Prazosin; Rats | 1994 |
Effects of nicotine on brain stem mechanisms of cardiovascular control.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Brain Stem; Cardiovascular Physiological Phenomena; Cardiovascular System; Clonidine; Heart Rate; Hexamethonium; Hexamethonium Compounds; Labetalol; Male; Nicotine; Physostigmine; Prazosin; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley | 1993 |
Time-dependent efficacy of antihypertensive agents in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Captopril; Circadian Rhythm; Clonidine; Felodipine; Heart Rate; Hypertension; Labetalol; Male; Metoprolol; Oxazoles; Prazosin; Propanolamines; Propranolol; Rats; Rats, Inbred SHR; Rilmenidine; Thiophenes | 1993 |
Transverse limb deficiency, facial clefting and hypoxic renal damage: an association with treatment of maternal hypertension?
Topics: Abnormalities, Drug-Induced; Adult; Child, Preschool; Facial Bones; Female; Fetal Death; Fetus; Humans; Hypertension; Hypoxia; Kidney; Labetalol; Limb Deformities, Congenital; Male; Middle Aged; Prazosin; Pregnancy | 1995 |
The preoperative management of phaeochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Blood Pressure; Female; Humans; Labetalol; Male; Middle Aged; Phenoxybenzamine; Pheochromocytoma; Prazosin; Preoperative Care; Retrospective Studies | 1998 |
Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Brain Chemistry; Catecholamines; Cytokines; Electroshock; Immunohistochemistry; Labetalol; Male; Prazosin; Propranolol; Rats; Rats, Inbred F344; Stress, Psychological; Tyrosine 3-Monooxygenase | 2005 |
Identification and profiling of novel α1A-adrenoceptor-CXC chemokine receptor 2 heteromer.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Allosteric Regulation; Animals; Arrestins; beta-Arrestins; Chemokines; CHO Cells; Cricetinae; HEK293 Cells; Humans; Inositol Phosphates; Labetalol; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Prazosin; Prostate; Protein Structure, Quaternary; Receptors, Adrenergic, alpha-1; Receptors, G-Protein-Coupled; Receptors, Interleukin-8B | 2012 |
Multiple cerebral infarctions related to famotidine-induced eosinophilia.
Topics: Acarbose; Adrenergic alpha-1 Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Calcium Channel Blockers; Cerebral Infarction; Diabetes Mellitus, Type 2; Diffusion Magnetic Resonance Imaging; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Famotidine; Humans; Hypertension; Hypoglycemic Agents; Labetalol; Male; Metformin; Middle Aged; Nifedipine; Peptic Ulcer; Prazosin; Sulfonylurea Compounds | 2012 |
The sympathetic nervous system is controlled by transient receptor potential vanilloid 1 in the regulation of body temperature.
Topics: Acrylamides; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Body Temperature; Body Temperature Regulation; Bridged Bicyclo Compounds, Heterocyclic; Fever; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Labetalol; Male; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Prazosin; Propranolol; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Sympathetic Nervous System; Telemetry; TRPV Cation Channels | 2015 |
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan | 2020 |